Bladder Cancer-related microRNAs With In Vivo Efficacy in Preclinical Models

Cancer Diagn Progn. 2021 Jul 3;1(4):245-263. doi: 10.21873/cdp.10033. eCollection 2021 Sep-Oct.

Abstract

Progressive and metastatic bladder cancer remain difficult to treat. In this review, we critique seven up-regulated and 25 down-regulated microRNAs in order to identify new therapeutic entities and corresponding targets. These microRNAs were selected with respect to their efficacy in bladder cancer-related preclinical in vivo models. MicroRNAs and related targets interfering with chemoresistance, cell-cycle, signaling, apoptosis, autophagy, transcription factor modulation, epigenetic modification and metabolism are described. In addition, we highlight microRNAs targeting transmembrane receptors and secreted factors. We discuss druggability issues for the identified targets.

Keywords: Apoptosis; bladder cancer-related targets; cell cycle; epigenetic modifiers; invasion and proliferation; migration; orthotopic and xenograft models; review; tumor growth and metastasis.

Publication types

  • Review